Aurora Cannabis Inc

Most Recent

  • uploads///Aphrias Short Interest
    Company & Industry Overviews

    Gauging the Bullish-Bearish Sentiment on Aphria

    The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Sector
    Company & Industry Overviews

    Investors: An Important Trend before Investing in Cannabis

    As of February 22, the median EV-to-EBITDA valuation multiple for the nine stocks was 25.1x. On February 8, the median multiple was 22.1x.

    By Adam Jones
  • uploads///Tobacco Use in Canada
    Company & Industry Overviews

    Why Product Landscape Design Matters for Cannabis Stocks

    The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies.

    By Adam Jones
  • uploads///EBITDA and EBITDA Margin
    Basic Materials

    SMG’s Margin Expectations Could Be Concerning

    The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.

    By Adam Jones
  • uploads///Chart
    Company & Industry Overviews

    MedMen’s Territory Expansion: The Recent Agreements

    MedMen (MMNFF) has entered into agreements with different companies to expand its footprint. We outline a few of the recent agreements below.

    By Mike Benson
  • uploads///marijuana _
    Company & Industry Overviews

    How Last Week Was for the Cannabis Sector

    Last week (ended April 27), cannabis-sector ETFs ended in negative territory.

    By Adam Jones
  • uploads///Tilray Kilograms Sold and Averaege Price
    Earnings Report

    Tilray’s Q2 2018 Results and Its Strategic Focus

    Tilray’s (TLRY) average selling prices and sales volume improved YoY in the second quarter. The company sold 1,514 kilograms during the quarter.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Sector
    Company & Industry Overviews

    More Valuations for the Cannabis Sector in October

    The median forward EV-to-EBITDA multiple for our nine cannabis companies on October 8 was 43.2x. That was 30% lower than September.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Do CGC, ACB, TLRY, and APHA Look Cheap?

    With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.

    By Adam Jones
  • uploads///Uhhled
    Earnings Report

    Cronos Group Invests in the Future

    Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///Aphria and Altria Stock
    Company & Industry Overviews

    Tobacco Companies and Their Newfound Interest in Cannabis

    On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company.

    By Adam Jones
  • uploads///stock trading monitor desk
    Company & Industry Overviews

    Innovative Industrial Properties Declared Q1 Dividend

    On March 12, Innovative Industrial Properties’ board declared its first-quarter dividend. The company declared a dividend of $0.45 per share.

    By Peter Neil
  • uploads///Gross Income and EBITDA Estimates
    Miscellaneous

    Aurora Cannabis: Analysts’ Projections

    Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

    By Adam Jones
  • uploads///
    Company & Industry Overviews

    Checking On Canopy Growth and Its Peers

    Canopy Growth is one of the strongest players in the cannabis industry with a market cap of ~24 billion Canadian dollars.

    By Adam Jones
  • uploads///Forward EV to Sales
    Miscellaneous

    Does Cronos Group Look Expensive Compared to Its Peers?

    Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    Take a Look at Valuations before Jumping into Cannabis Stocks

    Cannabis stocks have soared in recent weeks in anticipation of October 17, the date when recreational cannabis sales are slated to begin in Canada.

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Marijuana Movement: Why Do Celebrities Support It?

    Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.

    By Sushree Mohanty
  • uploads///IIPR
    Basic Materials

    Will IIPR Still Be an Investor Favorite Post Q3 Earnings?

    Innovative Industrial Properties (IIPR) is set to report its third-quarter results tomorrow. IIPR stock, up 67.2% year-to-date, has been investor favorite.

    By Sushree Mohanty
  • uploads///marijuana _
    Company & Industry Overviews

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

    By Adam Jones
  • uploads///Trump
    Cannabis

    What Does President Trump Think about Marijuana?

    President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”

    By Sushree Mohanty
  • uploads///cannabis _
    Miscellaneous

    Canaccord Genuity Raises Price Target for Canopy Growth

    On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///Vaping
    Cannabis

    Why Vaping May Not Be a Gold Mine for Cannabis Players

    In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.

    By Sirisha Bhogaraju
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis’s Revenue: Here’s What Analysts Expect

    Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Aurora Cannabis’s Price Target Cut by 30%

    Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

    By Margaret Patrick
  • uploads///marijuana
    Cannabis

    Marijuana Policy: Can California Shape It for the US?

    Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///SMG Analysts NTM Recommendations and Targets
    Basic Materials

    Scotts Miracle-Gro: Analysts’ Recommendations in February

    For Scotts Miracle-Gro, one analyst recommended a “strong buy,” three recommended a “buy,” and three recommended a “hold.”

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    Marijuana to Treat New Conditions in Minnesota

    In August 2020, chronic pain and age-related macular degeneration would be eligible for treatment under Minnesota’s medical marijuana program.

    By Margaret Patrick
  • uploads///can_
    Cannabis

    Cannabis Legalization: Four Governors Met in New York

    The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

    By Rajiv Nanjapla
  • uploads///seedling _
    Company & Industry Overviews

    TLRY, CGC, CRON, and CTST Continue to Slide on April 11

    The first half of April 11 proved to be yet another dampener for cannabis investors’ expectations.

    By Adam Jones
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///green _
    Company & Industry Overviews

    Biggest Gainers in the Cannabis Sector Last Week

    In the week ending April 5, the overall cannabis sector ended in the positive territory. HMMJ rose ~0.93% last week.

    By Adam Jones
  • uploads///Tilray Analysts NTM Recommendations and Targets
    Miscellaneous

    Tilray’s November Price Target and Recommendation Update

    Tilray (TLRY), which reported its earnings on November 13, missed both top-line and bottom-line consensus estimates.

    By Adam Jones
  • uploads///c
    Miscellaneous

    Canopy Growth Receives Target Price Upgrades

    Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.

    By Adam Jones
  • uploads///Cannabis
    Cannabis

    Cannabis in Mexico: Legalization Bill Is Ready for Voting!

    Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.

    By Sushree Mohanty
  • uploads///Mexico
    Cannabis

    Mexico Will Attempt to Legalize Marijuana in 2020

    Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.

    By Sushree Mohanty
  • uploads///green _
    Company & Industry Overviews

    Tilray Invests in ROSE LifeScience

    On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Comparing Cannabis Stocks’ EV-to-EBITDA Multiples

    In this part, we’ll compare how these producers’ multiples compare with each other.

    By Adam Jones
  • uploads///Canopy
    Cannabis

    Canopy Growth Looks for CEO, Linton Gets a New Role

    Canopy Growth took the market by surprise and let CEO Bruce Linton go. After leaving Canopy Growth, Linton joined three companies in an advisory role.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Revisiting Valuation Multiples for Cannabis Companies

    Recreational cannabis is close to being legalized in Canada, and producers are running at full bore to capture a piece of the market.

    By Adam Jones
  • uploads///hexo
    Cannabis

    HEXO: Analysts’ Target Price and Ratings

    CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///hemp _
    Company & Industry Overviews

    Cannabis Sector Closes Positively in the Week Ended April 13

    Last week (ended April 13), overall market sentiment was positive, with the S&P 500 rising 2% and the TSX 30 gaining 44 basis points.

    By Adam Jones
  • uploads///Chart Title
    Company & Industry Overviews

    The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades

    The cannabis sector remains hot for mergers and acquisitions as companies rush to capture a piece of the recreational cannabis market.

    By Adam Jones
  • uploads///canopy
    Consumer

    Canopy Growth Stock Rises, Oppenheimer Initiates Coverage

    Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.

    By Sushree Mohanty
  • uploads///Can_
    Cannabis

    What Do Analysts Recommend for Canopy Growth?

    On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.

    By Rajiv Nanjapla
  • uploads///Canopy_
    Cannabis

    Can Canopy Beat Q2 Estimates and Boost the Sector?

    This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

    By Rajiv Nanjapla
  • uploads///Cronos group
    Cannabis

    Cronos Group Joins Altria to Bet on Cannabidiol Market

    Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

    By Sushree Mohanty
  • uploads///canopy growth
    Cannabis

    Canopy Growth: Key Takeaways from Its Investor Call

    Yesterday, Canopy Growth CFO Mike Lee seemed optimistic when he presented at the Barclays 2019 Global Consumer Staples Conference.

    By Rajiv Nanjapla
  • uploads///Preferred Channel
    Company & Industry Overviews

    Where Canadians Would Prefer to Buy Recreational Marijuana

    In the previous part of this series, we briefly discussed how the different active components of the cannabis plant make it a more complex product than tobacco and alcohol.

    By Adam Jones
  • uploads///mariju
    Cannabis

    Marijuana Vape Products Expected in Alberta Stores

    AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

    By Rajiv Nanjapla
  • uploads///cannabis _
    Company & Industry Overviews

    Canopy Growth Is Optimistic about Cannabis Market

    Recreational cannabis sales began in Canada on October 17. Canada is only the second country after Uruguay to legalize cannabis.

    By Adam Jones
  • uploads///arnel hasanovic oWSXdeASg unsplash
    Cannabis

    Why Canopy Growth Isn’t Happy with Apple

    Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.

    By Sushree Mohanty
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What to Expect from Its Q4 Results

    Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.

    By Sushree Mohanty
  • uploads///south dakota cannabis
    Cannabis

    South Dakota Plans for Marijuana Legalization amid COVID-19

    Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.

    By Sushree Mohanty
  • Cannabis

    Marijuana Legalization Continues: Wisconsin Steps Up!

    Marijuana laws are pretty strict in Wisconsin. Although cannabis is spreading its roots across US states, it’s still illegal at the federal level. President Trump and his administration want states to decide. Florida, New York, and Minnesota are all gearing up to legalize adult-use cannabis. Now, Wisconsin is pushing to legalize medical marijuana. Let’s see […]

    By Adam Jones
  • uploads///Aphria
    Cannabis

    Is Aphria a Good Cannabis Pick for 2020?

    Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.

    By Sushree Mohanty
  • uploads///medmen upcoming results
    Cannabis

    Will MedMen Deliver Any Good News in Its Q2 Earnings?

    MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis 2.0: Aphria Gets Ready for Edibles Market

    Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.

    By Sushree Mohanty
  • uploads///marijuana hashish leaf flowerpot
    Cannabis

    Big News: Cannabis Edibles in Alberta Stores

    Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

    By Rajiv Nanjapla
  • uploads///trump
    Cannabis

    Elizabeth Warren Unveils Plan for Marijuana Legalization

    According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.

    By Sushree Mohanty
  • uploads///herb _
    Company & Industry Overviews

    Aurora Cannabis Inches Closer to Acquiring ICC Labs

    A special meeting will be held on November 6 to urge shareholders to approve the arrangement between Aurora Cannabis and ICC Labs.

    By Adam Jones
  • uploads///
    Cannabis

    Medical Marijuana Is Booming in OK, Struggles in OH

    Medical marijuana is a hit in Ohio since it allowed it in 2016. Recreational cannabis is still not allowed. Notably, data has shown that Ohio’s medical cannabis industry is booming since it started in 2019. However, the medical cannabis industry is facing some setbacks as well. So, let’s take a look at it. Ohio and […]

    By Sushree Mohanty
  • uploads///california marijuana future
    Cannabis

    Marijuana Industry: Opportunities in California amid COVID-19

    Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///Medical cannabis
    Cannabis

    Medical Cannabis in Brazil Is Coming

    According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis Sector 2019 Review and 2020 Outlook

    Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

    By Sushree Mohanty
  • uploads///cannabis _
    Cannabis

    How Cannabis Stocks Fared Last Week

    Tilray was the top performer in the cannabis sector last week with a rise of 49% as a result of better-than-expected second-quarter earnings and guidance.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    Is New Jersey Closer to Legalizing Recreational Cannabis?

    If New Jersey passes the bill to legalize recreational cannabis, it will become the 11th state to legalize recreational cannabis in the United States.

    By Adam Jones
  • uploads///marijuana
    Cannabis

    Marijuana: Will Trump Have an Edge over Biden?

    With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Miscellaneous

    Aurora Cannabis: Analysts’ Target Price after Its Earnings

    Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    CBD: Japan Welcomes NBEV, Stock Pops

    Today, New Age Beverages Corporation (NBEV) announced that it would launch its CBD (cannabidiol) based products. Share prices jumped by 14.96% to $3.20.

    By Margaret Patrick
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: O’Rourke Blazes His 2020 Campaign

    Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.

    By Sushree Mohanty
  • uploads///Sales Channel
    Miscellaneous

    Aurora Cannabis: Does Investment in Liquor Stores Fit Framework?

    With the opportunity for private players to run cannabis stores in British Columbia and Alberta, the partnership of Aurora Cannabis and Liquor Stores NA could come at an opportune time.

    By Adam Jones
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: South Dakota Does What Trump Said!

    Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.

    By Sushree Mohanty
  • uploads///green _
    Basic Materials

    Scotts Miracle-Gro Explores Opportunities in Cannabis Market

    SMG’s partnership with the Flowr Corporation could give it an opportunity to pursue options to enter the cannabis cultivation business.

    By Adam Jones
  • uploads///Aphria
    Cannabis

    Aphria: Why Jefferies Recommends a ‘Buy’

    Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.

    By Sushree Mohanty
  • uploads///Canopy
    Cannabis

    Canopy Gets Estimates Revised by Analysts for 2020

    Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, WEED, ACB, and CTST

    The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis in Kansas: Residents Are Taking Action

    Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it’s illegal in Kansas. Even having a small amount is considered a crime.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Stock and Peers Are Struggling

    Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note

    By Sushree Mohanty
  • uploads///Canopy Growth Stock on March
    Company & Industry Overviews

    Why Alcaliber Makes Sense for Canopy Growth

    On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.

    By Adam Jones
  • uploads///canopy growth pi financial
    Cannabis

    Canopy Growth: Why PI Financial Suggests a ‘Sell’

    Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Will Santa Claus Rally Boost Cannabis Stocks?

    On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.

    By Margaret Patrick
  • uploads///AdobeStock_
    Basic Materials

    What to Expect from IIPR’s Earnings for Q3

    Innovative Industrial Properties (IIPR) is scheduled to release its Q3 earnings results on November 6. Find out what cannabis investors can expect.

    By Margaret Patrick
  • uploads///Joe Biden
    Cannabis

    Joe Biden Won’t Legalize Cannabis—Why?

    Although Joe Biden supported medical cannabis in his previous presidential campaigns, he has always opposed full-scale legalization.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Canada’s Cannabis Act C-45 Makes Progress in the Senate

    On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.

    By Adam Jones
  • uploads///texas
    Cannabis

    Marijuana in Texas: Five Things You Should Know

    Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.

    By Sushree Mohanty
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    Price Target Update for Canopy Growth in January

    Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.

    By Adam Jones
  • uploads///matthias wagner QrqeusbpFMM unsplash
    Cannabis

    Why Canopy Growth Is Partnering with Drake

    The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.

    By Sushree Mohanty
  • uploads///Global
    Earnings Report

    How Tilray Is Advancing in International Markets

    In its earnings call, Tilray (TLRY) stated that its Canadian entity will serve as a production hub to meet global cannabis demand.

    By Adam Jones
  • uploads///event _
    Cannabis

    Medical Cannabis: A Hot Topic at Events Across the World

    These days, experts are discussing the pros and cons of medical cannabis at multiple conferences and summits around the world.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • uploads///get budding BuBSErSL_M unsplash
    Cannabis

    Why Marijuana Revenues in Colorado Keep Rising

    Colorado reported $1.16 billion in marijuana sales in the first eight months of 2019. In 2018, the state reported marijuana sales of $1.54 billion.

    By Margaret Patrick
  • uploads///KHC EPS
    Cannabis

    Key Takeaways on the SAFE Banking Act Hearing

    On Tuesday, the US Senate held a hearing on the SAFE (Secure and Fair Enforcement) Banking Act. On March 26, the House Committee passed the act. The act will need to pass the Senate before it is sent to the US president. If passed, the act would greatly help US cannabis businesses. What is the […]

    By Market Realist
  • uploads///marijuana _
    Company & Industry Overviews

    Cannabis Sector Update for the Week Ended May 4

    Last week was broadly positive for the cannabis sector. The ETF Horizons Marijuana Life Sciences (HMMJ) rose 2.4%.

    By Adam Jones
  • uploads///cannabis stocks
    Cannabis

    Which Cannabis Stocks Have Lost More than 40% in 2019?

    The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.

    By Sushree Mohanty
  • uploads///cann
    Cannabis

    Cannabis Legalization: Is It Time for the US to Act?

    Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.

    By Sushree Mohanty
  • Cannabis

    Cannabis 2.0 Legalization: Canada Is Ready

    Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]

    By Sushree Mohanty
  • uploads///green _
    Company & Industry Overviews

    Aphria: Last Week Was Eventful

    On December 27, Aphria came in play after Green Growth Brands announced its bid to take over the company for 11 Canadian dollars per share.

    By Adam Jones
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.